|
STOK Stoke Therapeutics Inc 1623526 |
| Balance Sheet |
|
Current Assets
|
253,612,000 |
|
Assets
|
293,319,000 |
|
Current Liabilities
|
49,865,000 |
|
Liabilities
|
61,206,000 |
|
Equity
|
232,113,000 |
|
Shares Out
|
52,648,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-63,658,000 |
|
Investing Cash Flow
|
-108,294,000 |
| Market Analysis |
Market Cap
|
783,136,025 |
|
Price
|
8.15 |
|
BVPS
|
4.41 |
|
PB
|
1.83 |
|
EPS
|
-2.18 |
|
PS
|
40.00 |
|
FCF
|
-171,952,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view STOK documents filed with the SEC.
STOK Filings
Clear
